The goal of this clinical trial is to learn if a kidney transplant-specific comprehensive geriatric assessment (KT-CGA) can improve the way older adults are assessed for kidney transplantation. The main questions it aims to answer are: Is it feasible and acceptable to deliver a KT-CGA alongside routine transplant assessment in older adults with advanced kidney disease? What is the effect of KT-CGA on decision-making about transplant listing and on patient-reported outcomes such as quality of life and frailty? Researchers will compare participants who receive the KT-CGA plus usual care to those who receive usual care alone. Participants will: Continue with their usual transplant assessment process If randomised to the intervention group, also complete the KT-CGA (a structured set of questionnaires, short memory and function tests, and discussions about wellbeing and support needs, taking about 45-60 minutes)
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Proportion of eligible patients who consented and were randomised
Timeframe: From first eligible patient approached through completion of recruitment (anticipated 12 months)
Proportion of participants allocated to KT-CGA who completed the full assessment
Timeframe: At intervention visit (single study visit following randomisation, within 4 weeks of allocation)
Duration of KT-CGA visit
Timeframe: At intervention visit (single study visit following randomisation, within 4 weeks of allocation)
Reach of KT-CGA
Timeframe: From first intervention delivered through completion of recruitment (anticipated 12 months)
Fidelity of KT-CGA delivery
Timeframe: At intervention visit (single study visit following randomisation, within 4 weeks of allocation)
Participant acceptability of randomisation and KT-CGA
Timeframe: Immediately post-intervention visit (same day as KT-CGA visit)